Text

Microbial particles may boost the effectiveness of immunotherapy in stomach cancer

Bacterial extracellular vesicles released by L. salivarius activate immune cells, boosting the effectiveness of immunotherapy in stomach cancer.

Hidden gut bacteria may be key to a healthy microbiota

Uncultured gut bacteria, particularly one group called CAG-170, are key contributors to a healthy microbiota. 

From tradition to innovation: the new age of fermented cosmetic ingredients

Building the future with advanced biotechnology.

The Fastest Lab on Earth

Why Formula 1 will build the future of personalised medicine before medicine does.

Vitafoods Europe 2026: from market expansion to innovation in action

The report by MicrobiomePost distills key trends from Vitafoods Europe 2026.

Region-specific infant gut bacteria may pave the way for tailored probiotics

Bifidobacterium longum and B. infantis are distinct species with strains adapted to local diets, highlighting the importance of developing geographically tailored infant probiotics.

Gut protein blocks harmful bacteria and protects intestinal health

HMGB1 is a key protein that blocks bacterial adhesion and virulence, protecting intestinal cells and helping to maintain a healthy microbiota.

Healthy donor fecal transplants may boost immunotherapy in kidney cancer

Modifying the microbiota through a fecal transplant can be safely combined with immunotherapy in people with kidney cancer.

Gut microbe and its metabolite may protect the heart from atrial fibrillation

Restoring R. gnavus or supplementing isovaleric acid could be a promising microbiota–based strategy to prevent or treat atrial fibrillation. 

Your skin is speaking. Who’s listening?

A new generation of biosensor-equipped wristbands is learning to read the chemical language of the skin microbiome in real time.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.